MedBen Rx Blog
Need to Submit a RxDC Report? MedBen Has You Covered
As you may recall, the Consolidated Appropriations Act of 2021 (CAA) requires group health plans to submit to the Centers for Medicare & Medicaid Services information about prescription drugs and health care spending. This data submission is called RxDC (for...
Benefit Preservation Helps Lower Specialty Drug Spend
High-cost specialty drugs can make up more than 60% of a health plan’s pharmacy costs. MedBen Rx’s benefit preservation program is designed to make certain that members have continued access to medications while reducing specialty drug spend to the greatest...
MedBen Benefits Advisory Conference Explores the State of the Industry
Over 70 guests from seven states attended the MedBen 2025 Benefits Advisory Conference on January 30. Featuring some of the most respected names in the industry, this invitation-only event provided brokers with an extensive look at the state of benefits...
Manage Drug Spend and Improve Outcomes with Pharmacogenomics
Now available through MedBen Rx, pharmacogenomic testing is transforming health care through safer and more effective personalized medicine. Determining how genes affect a person’s response to drugs not only improves patient outcomes, but it also helps control...
Major PBMs Pocketed Nearly $9 Billion through Specialty Drug Pricing Practices, FTC Finds
Through specialty generic drug markups, three major pharmacy benefit managers (PBMs) earned a collective $7.3 billion above estimated acquisition costs over a five-year period, according to an interim report released by the Federal Trade Commission (FTC)....
Drugmakers Raising Prices on Over 250 Medications in Early 2025
Pharmaceutical companies are planning to increase prices on over 250 brand-name medications in the United States at the beginning of 2025, according to an analysis by health care research firm 3 Axis Advisors. That's a notable drop from last January, during which more...
Optimize Your Health through Nutrigenomic Testing
Nutrigenomic testing, available through MedBen Rx, analyzes an individual’s genetic makeup to understand how their genes influence their response to nutrition, diet, and lifestyle factors. As the list below shows, the wealth of information uncovered through...
Rise in Obesity Drug Use Leads to Drop in More Effective Surgical Alternative
Bariatric surgeries to treat obesity dropped 25.6% from 2022 to 2023, while prescriptions for GLP-1 drugs more than doubled during that period, according to a new study of privately insured Americans with obesity. However, those who opt for the surgery are...
Harness the Power of Precision Medicine with Genomic Testing
Genomic testing is revolutionizing precision medicine, offering unprecedented insights into how your body interacts with medications and nutrients. MedBen Rx offers pharmacogenomic and nutrigenomic tests that can help optimize your employees’ health care and...
Prepping for the 2025 Health Care Cost Forecast
Health care costs in the United States are projected to see their steepest rise in over a decade during 2025, with multiple industry analyses forecasting increases between 7% and 8% year-over-year (see table below). However, MedBen offers solutions that directly...
Disparate PBM Pricing Practices Put Independent Pharmacies at Risk of Closure
KFF Health News reports on the disparity between pharmacy benefit manager (PBM) payments to large pharmacy chains compared to small drugstores: “[An American Pharmacy Cooperative] analysis early this year showed chains were paid well beyond the family business...
Rise in Specialty Drug Spend Spurs Innovative Cost-Saving Solutions
Specialty drugs continue to drive up pharmacy costs, accounting for over 50% of total drug spend for many self-funded health plans, despite being used by a small percentage of patients. But pharmaceutical and administrative solutions are available to help reduce that...